Is Quantum BioPharma Stock a Good Investment?
Quantum BioPharma Investment Advice | QNTM |
- Examine Quantum BioPharma's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Quantum BioPharma's leadership team and their track record. Good management can help Quantum BioPharma navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Quantum BioPharma's business and its evolving consumer preferences.
- Compare Quantum BioPharma's performance and market position to its competitors. Analyze how Quantum BioPharma is positioned in terms of product offerings, innovation, and market share.
- Check if Quantum BioPharma pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Quantum BioPharma's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Quantum BioPharma stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Quantum BioPharma is a good investment.
Sell | Buy |
Hold
Market Performance | Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Quantum BioPharma Stock
Researching Quantum BioPharma's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Quantum BioPharma recorded a loss per share of 13.0. The entity had not issued any dividends in recent years. The firm had 1:65 split on the 15th of August 2024.
To determine if Quantum BioPharma is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Quantum BioPharma's research are outlined below:
| Quantum BioPharma had very high historical volatility over the last 90 days | |
| Quantum BioPharma has a very high chance of going through financial distress in the upcoming years | |
| Quantum BioPharma was previously known as HUGE Old and was traded on NASDAQ Exchange under the symbol HUGE. | |
| Net Loss for the year was (17.9 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quantum BioPharma generates negative cash flow from operations | |
| Quantum BioPharma has a very weak financial position based on the latest SEC disclosures | |
| About 14.0% of the company outstanding shares are owned by corporate insiders |
Quantum BioPharma's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.17 M.Basic technical analysis of Quantum Stock
As of the 7th of January, Quantum BioPharma holds the Coefficient Of Variation of 7446.64, risk adjusted performance of 0.0199, and Semi Deviation of 6.94. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Quantum BioPharma, as well as the relationship between them. Please check Quantum BioPharma variance, as well as the relationship between the value at risk and skewness to decide if Quantum BioPharma is priced some-what accurately, providing market reflects its current price of 3.84 per share. Given that Quantum BioPharma has jensen alpha of 0.0836, we recommend you to check out Quantum BioPharma's recent market performance to make sure the company can sustain itself at a future point.Understand Quantum BioPharma's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Quantum BioPharma's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0199 | |||
| Market Risk Adjusted Performance | 0.1298 | |||
| Mean Deviation | 5.5 | |||
| Semi Deviation | 6.94 | |||
| Downside Deviation | 7.16 | |||
| Coefficient Of Variation | 7446.64 | |||
| Standard Deviation | 8.07 | |||
| Variance | 65.17 | |||
| Information Ratio | 0.01 | |||
| Jensen Alpha | 0.0836 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.0112 | |||
| Treynor Ratio | 0.1198 | |||
| Maximum Drawdown | 49.74 | |||
| Value At Risk | (13.29) | |||
| Potential Upside | 12.29 | |||
| Downside Variance | 51.31 | |||
| Semi Variance | 48.18 | |||
| Expected Short fall | (6.56) | |||
| Skewness | 0.7459 | |||
| Kurtosis | 3.22 |
| Risk Adjusted Performance | 0.0199 | |||
| Market Risk Adjusted Performance | 0.1298 | |||
| Mean Deviation | 5.5 | |||
| Semi Deviation | 6.94 | |||
| Downside Deviation | 7.16 | |||
| Coefficient Of Variation | 7446.64 | |||
| Standard Deviation | 8.07 | |||
| Variance | 65.17 | |||
| Information Ratio | 0.01 | |||
| Jensen Alpha | 0.0836 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.0112 | |||
| Treynor Ratio | 0.1198 | |||
| Maximum Drawdown | 49.74 | |||
| Value At Risk | (13.29) | |||
| Potential Upside | 12.29 | |||
| Downside Variance | 51.31 | |||
| Semi Variance | 48.18 | |||
| Expected Short fall | (6.56) | |||
| Skewness | 0.7459 | |||
| Kurtosis | 3.22 |
Consider Quantum BioPharma's intraday indicators
Quantum BioPharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Quantum BioPharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Quantum BioPharma time-series forecasting models is one of many Quantum BioPharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Quantum BioPharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Quantum Stock media impact
Far too much social signal, news, headlines, and media speculation about Quantum BioPharma that are available to investors today. That information is available publicly through Quantum media outlets and privately through word of mouth or via Quantum internal channels. However, regardless of the origin, that massive amount of Quantum data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Quantum BioPharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Quantum BioPharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Quantum BioPharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Quantum BioPharma alpha.
Quantum BioPharma Corporate Management
| Kevin Cassidy | Vice QualityLucid | Profile | |
| Donal CPA | Chief Officer | Profile | |
| Jason Sawyer | Head Acquisitions | Profile | |
| Maryann Adesso | Corporate Secretary | Profile | |
| Nathan CPA | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quantum BioPharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quantum BioPharma. If investors know Quantum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quantum BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Quantum BioPharma's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Quantum BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quantum BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.